Fosnetupitant

Major

Fosnetupitant Estradiol Topical Divigel Increased exposure of CYP3A4 substrate Details Fosnetupitant Estradiol Transdermal Patch Alora® Increased exposure of CYP3A4 substrate Details Fosnetupitant Everolimus Afinitor Increased exposure of CYP3A4 substrate Details Fosnetupitant Felodipine Plendil® Increased exposure of CYP3A4 substrate Details Fosnetupitant Fentanyl Transdermal Patch Duragesic® Increased exposure of CYP3A4 substrate Details Fosnetupitant Finerenone Kerendia Increased finerenone exposure and an increased risk of finerenone-related adverse effects Details Fosnetupitant Guanfacine Intuniv Increased exposure of CYP3A4 substrate Details Fosnetupitant Hydrocortisone Ala-Cort Increased exposure of CYP3A4 substrate Details Fosnetupitant Hydrocortisone Injection A-Hydrocort® Increased exposure of CYP3A4 substrate Details Fosnetupitant Ibrutinib Imbruvica Increased ibrutinib exposure Details Fosnetupitant Infigratinib Truseltiq Increased infigratinib plasma concentrations Details Fosnetupitant Irinotecan Camptosar Increased exposure to chemotherapy agent and increased risk of side effects Details Fosnetupitant Irinotecan Injection Camptosar Increased exposure to chemotherapy agent and increased risk of side effects Details Fosnetupitant Irinotecan Lipid Complex Injection Onivyde® Increased exposure to chemotherapy agent and increased risk of side effects Details Fosnetupitant Ivabradine Corlanor Increased exposure of CYP3A4 substrate Details Fosnetupitant Lefamulin Xenleta Increased lefamulin exposure and an increased risk of lefamulin-related adverse reactions Details Fosnetupitant Letermovir Injection Prevymis Increased CYP3A substrate exposure Details Fosnetupitant Loperamide Diamode Increased loperamide exposure and an increased risk of loperamide-related adverse reactions Details Fosnetupitant Lovastatin Altocor® Increased exposure of CYP3A4 substrate Details Fosnetupitant Lumateperone Caplyta Increased lumateperone exposure and increased risk of lumateperone-related adverse reactions Details Fosnetupitant Lurasidone Latuda Increased exposure of CYP3A4 substrate Details Fosnetupitant Lurbinectedin Injection Zepzelca Increased lurbinectedin exposure and an increased risk of lurbinectedin-related adverse reactions Details Fosnetupitant Maraviroc Selzentry Increased exposure of CYP3A4 substrate Details Fosnetupitant Methylergonovine Methergine Increased methylergonovine exposure and an increased risk of vasospasm, cerebral ischemia and/or ischemia of extremities Details Fosnetupitant Midazolam Nasal Spray Nayzilam Increased exposure of CYP3A4 substrate Details Fosnetupitant Midazolam Injection Nayzilam Increased exposure of CYP3A4 substrate Details Fosnetupitant Mitapivat Aqvesme Increased mitapivat exposure Details Fosnetupitant Naloxegol Movantik Increased exposure of CYP3A4 substrate Details Fosnetupitant Nateglinide Starlix® Increased exposure of CYP3A4 substrate Details Fosnetupitant Neratinib Nerlynx Increased exposure of CYP3A4 substrate Details Fosnetupitant Nifedipine Adalat® Increased exposure of CYP3A4 substrate Details Fosnetupitant Nisoldipine Sular Increased exposure of CYP3A4 substrate Details